Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Rational Design, Synthesis, and In Vitro Neuroprotective Evaluation of Novel Glitazones for PGC-1α Activation via PPAR-γ: a New Therapeutic Strategy for Neurodegenerative Disorders.

Justin A, Mandal S, Prabitha P, Dhivya S, Yuvaraj S, Kabadi P, Sekhar SJ, Sandhya CH, Wadhwani AD, Divakar S, Bharathi JJ, Durai P, Prashantha Kumar BR.

Neurotox Res. 2019 Nov 28. doi: 10.1007/s12640-019-00132-9. [Epub ahead of print]

PMID:
31782098
2.

Microneedle - Future prospect for efficient drug delivery in diabetes management.

Jana BA, Wadhwani AD.

Indian J Pharmacol. 2019 Jan-Feb;51(1):4-10. doi: 10.4103/ijp.IJP_16_18. Review.

3.

Novel glitazones as PPARγ agonists: molecular design, synthesis, glucose uptake activity and 3D QSAR studies.

Mandal SP, Garg A, Prabitha P, Wadhwani AD, Adhikary L, Kumar BRP.

Chem Cent J. 2018 Dec 19;12(1):141. doi: 10.1186/s13065-018-0508-0.

4.

An effective treatment approach of DPP-IV inhibitor encapsulated polymeric nanoparticles conjugated with anti-CD-4 mAb for type 1 diabetes.

Thondawada M, Wadhwani AD, S Palanisamy D, Rathore HS, Gupta RC, Chintamaneni PK, Samanta MK, Dubala A, Varma S, Krishnamurthy PT, Gowthamarajan K.

Drug Dev Ind Pharm. 2018 Jul;44(7):1120-1129. doi: 10.1080/03639045.2018.1438460. Epub 2018 Feb 21.

PMID:
29430979
5.

Curcumin loaded chitosan nanoparticles impregnated into collagen-alginate scaffolds for diabetic wound healing.

Karri VV, Kuppusamy G, Talluri SV, Mannemala SS, Kollipara R, Wadhwani AD, Mulukutla S, Raju KR, Malayandi R.

Int J Biol Macromol. 2016 Dec;93(Pt B):1519-1529. doi: 10.1016/j.ijbiomac.2016.05.038. Epub 2016 May 11.

PMID:
27180291

Supplemental Content

Loading ...
Support Center